[Effect of caerulein on pancreatic endocrine and exocrine secretion from the perfused rat pancreas (author's transl)]
- PMID: 344078
- DOI: 10.1507/endocrine1927.54.1_78
[Effect of caerulein on pancreatic endocrine and exocrine secretion from the perfused rat pancreas (author's transl)]
Abstract
Several investigations in vivo and in vitro have shown that gastro-intestinal hormones stimulate insulin secretion. However, the reports on the insulinotropic activity of pancreozymin are contradictory. The conflicting results are probably due to the fact that pure native preparation of this hormone has not been obtained in "physiologic" doses. In the present study this problem has been investigated by exposing rat pancreas to caerulein in vitro. Caerulein, an active decapeptide isolated from the skin of the Australian amphibia Hyla caerulea, resembles pancreozymin in chemical structure, including C-terminus. This active polypeptide of nonmammalian origin has been shown to possess all the biological activities of pancreozymin. The present investigation was undertaken to evaluate the significance of the interactions of exocrine and endocrine pancreas using perfused rat pancreas in vitro. Biphasic insulin release was demonstrated with caerulein at concentrations higher than 1 ng/ml. Insulin response of the first phase was proportional to the dose up to 1 microgram/ml. The second phase of insulin release was, however, almost constant, regardless of the concentrations of caerulein. Release of glucagon was stimulated by the same concentrations of caerulein which stimulated insulin release. Maximal response of the pancreatic amylase and pancretic juice output were observed with 1 ng/ml of caerulein. With higher doses, significantly less secretory responses were observed. The dissociation of the response to caerulein between endocrine and exocrine pancreas was found.
Similar articles
-
Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.J Clin Invest. 1979 Mar;63(3):478-84. doi: 10.1172/JCI109325. J Clin Invest. 1979. PMID: 372241 Free PMC article.
-
Effect of caerulein on exocrine and endocrine pancreas in the rat.Endocrinology. 1979 Dec;105(6):1396-9. doi: 10.1210/endo-105-6-1396. Endocrinology. 1979. PMID: 387384
-
[Effect of caerulein on the exocrine and endocrine pancreas].Nihon Shokakibyo Gakkai Zasshi. 1977 Sep;74(9):1121-6. Nihon Shokakibyo Gakkai Zasshi. 1977. PMID: 335125 Japanese. No abstract available.
-
[The effect of caerulein or cholecystokinin on pancreatic endocrine and exocrine secretion in the isolated perfused rat pancreas (author's transl)].Nihon Naibunpi Gakkai Zasshi. 1980 Sep 20;56(9):1200-13. doi: 10.1507/endocrine1927.56.9_1200. Nihon Naibunpi Gakkai Zasshi. 1980. PMID: 6160065 Japanese. No abstract available.
-
Pharmacology, clinical uses, and adverse effects of ceruletide, a cholecystokinetic agent.Pharmacotherapy. 1982 Jul-Aug;2(4):223-34. doi: 10.1002/j.1875-9114.1982.tb03189.x. Pharmacotherapy. 1982. PMID: 6763205 Review.